GJB1 and metabolic dysfunction-associated steatohepatitis: These results suggest that Cx32 dysfunction enhances NASH-related hepatotoxicity in the HFD–DMN model, as was the case with the Cx32ΔTg-MCDD model in our previous report (Sagawa et al. 2015).